Access cutting-edge advanced solid tumors treatment through this clinical trial at a research site in Denver. Study-provided care at no cost to qualified participants.
Access advanced solid tumors specialists in Denver at no cost
This study follows strict safety protocols and ethical guidelines
All study-related advanced solid tumors treatment provided free
Phase 1/2a Clinical Trial of BI-1206, a Monoclonal Antibody to CD32b (FcγRIIB), in Combination with Pembrolizumab in Subjects with Advanced Solid Tumors Previously Treated with Anti-PD-1 or Anti-PD-L1 Antibodies
Sponsor: BioInvent International AB
Check if you qualify for this advanced solid tumors clinical trial in Denver, CO
If you're searching for advanced solid tumors treatment options in Denver, CO, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Denver research site is actively enrolling participants for this clinical trial. You'll receive care from experienced advanced solid tumors specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.